Strategies to minimize heterogeneity and optimize clinical trials in Acute Respiratory Distress Syndrome (ARDS): Insights from mathematical modelling
Open Access
- 13 January 2022
- journal article
- research article
- Published by Elsevier BV in EBioMedicine
- Vol. 75, 103809
- https://doi.org/10.1016/j.ebiom.2021.103809
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Emerging markers in cardiovascular disease: Where does angiotensin‐converting enzyme 2 fit in?Clinical and Experimental Pharmacology and Physiology, 2013
- Acute Respiratory Distress SyndromeJAMA, 2012
- Mathematical and Statistical Modeling in Cancer Systems BiologyFrontiers in Physiology, 2012
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationThe New England Journal of Medicine, 2011
- Asthma endotypes: A new approach to classification of disease entities within the asthma syndromeJournal of Allergy and Clinical Immunology, 2011
- Analyzing the Climate Sensitivity of the HadSM3 Climate Model Using Ensembles from Different but Related ExperimentsJournal of Climate, 2009
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal CancerThe New England Journal of Medicine, 2008
- Metagenes and molecular pattern discovery using matrix factorizationProceedings of the National Academy of Sciences of the United States of America, 2004
- Modelling viral and immune system dynamicsNature Reviews Immunology, 2002
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996